RAB3B and cancer: Using the cBioPortal platform for analyzing gene and expression data from various cancers, we found that RAB3B had mutations in most cancers, with the highest mutation rate in Ovarian Epithelial Tumor, Miscellaneous Neuroepithelial Tumor, and Sarcoma.